FDA’s perspective on human factors and usability engineering has evolved.
A review of the important aspects of risk management and post-market surveillance processes, and how to resolve common concerns.
The company’s Bakken Research Centre in the Netherlands is centrally located for technology development and collaboration with physicians.
A summary of the new and revised changes in ISO 13485, the second Draft International Standard (DIS2).
Charlie Chi, former CEO of OtisMed Corp, is sentenced to prison for shipping adulterated medical devices into interstate commerce.